|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
intestine stem cell mt-nd2 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3
from Li et al., 2022
|
|
digestive tract morphogenesis decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
intestine ab2-pcna labeling decreased distribution, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 4
from Li et al., 2022
|
|
whole organism rpl32 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestinal epithelial cell tcnba expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3
from Li et al., 2022
|
|
intestine decreased length, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
whole organism rps17 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rps6 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rpl5b expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
translation decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 6
from Li et al., 2022
|
|
whole organism rpl15 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine lumen decreased width, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
intestine nucleotide biosynthetic process decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine fabp2 expression spatial pattern, ameliorated
|
mycnzf4252/zf4252
|
chemical treatment by environment: leucine
|
Fig 7
from Li et al., 2022
|
|
intestinal epithelial cell baiap2l1a expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3
from Li et al., 2022
|
|
intestinal epithelial cell lmo7a expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3
from Li et al., 2022
|
|
whole organism rpl12 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
goblet cell decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
pectoral fin bud hand2 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
rRNA processing decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 6
from Li et al., 2022
|
|
whole organism rpl17 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rps9 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine cell population proliferation decreased occurrence, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3 ,
Fig 4
from Li et al., 2022
|
|
whole organism rpl3 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestinal epithelial cell fabp6 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 3
from Li et al., 2022
|
|
intestine reactive oxygen species biosynthetic process decreased occurrence, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
whole organism rpl30 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
pectoral fin bud hand2 expression decreased distribution, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
whole organism Ab1-puromycin labeling decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 6
from Li et al., 2022
|
|
whole organism rpl36 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rps27l expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine fabp2 expression decreased distribution, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2 ,
Fig 7
from Li et al., 2022
|
|
whole organism rpl19 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine cell death normal occurrence, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 4
from Li et al., 2022
|
|
intestine nucleoside metabolic process decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rps4x expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine ribosome assembly decreased process quality, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine fabp2 expression amount, ameliorated
|
mycnzf4252/zf4252
|
chemical treatment by environment: leucine
|
Fig 7
from Li et al., 2022
|
|
swim bladder uninflated, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
pharyngeal arch cartilage element malformed, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
whole organism rps8a expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine Ab1-puromycin labeling decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 6
from Li et al., 2022
|
|
whole organism rps20 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
whole organism rpl4 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine Ab1-puromycin labeling spatial pattern, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 6
from Li et al., 2022
|
|
whole organism rps3a expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
TOR signaling decreased occurrence, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 7
from Li et al., 2022
|
|
whole organism rpl18 expression decreased amount, abnormal
|
mycnzf4252/zf4252
|
standard conditions
|
Fig 5
from Li et al., 2022
|
|
intestine EGFP expression spatial pattern, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
intestine cell population proliferation decreased occurrence, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 4
from Li et al., 2022
|
|
digestive tract development decreased process quality, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
intestine cell death normal occurrence, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 4
from Li et al., 2022
|
|
intestine EGFP expression decreased distribution, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 2
from Li et al., 2022
|
|
intestine cell cycle decreased process quality, abnormal
|
mycnzf4252/zf4252; zf3097Tg/zf3097Tg
|
standard conditions
|
Fig 4
from Li et al., 2022
|